Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

Clinical trial NCT00879814 · COMPLETED

Trial details

NCT number: NCT00879814
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Meningitis, Meningococcal

Start date: 2009-04-01
Primary completion: 2012-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.